AdvisorShares Investments’s Indaptus Therapeutics INDP Stock Holding History

AdvisorShares Investments’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,955	Closed	-$1.54M	–	213
2021 Q2	$1.54M	Hold	3,955	–	–	0.21%	64
2021 Q1	$1.94M	Buy	3,955 +3,216	+435%	+$1.69M	0.24%	49
2020 Q4	$286K	Buy	739 +501	+211%	+$219K	0.07%	108
2020 Q3	$131K	Buy	238 +36	+18%	+$26.5K	0.01%	126
2020 Q2	$128K	Buy	202 +15	+8%	+$9.27K	0.05%	121
2020 Q1	$80K	Buy	187 +16	+9%	+$12.1K	0.07%	93
2019 Q4	$192K	Buy	+171	New	+$236K	0.12%	127

Other funds holding INDP

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AdvisorShares Investments's INDP Position: Q3 2021 in Review

AdvisorShares Investments sold out of Indaptus Therapeutics (INDP) in Q3 2021, closing a stake of 3,955 shares — an estimated $1.54M sold.

AdvisorShares Investments first reported a position in INDP in Q4 2019 and held it in 7 quarters. The position peaked at $1.94M in Q1 2021. 14 funds tracked by Wall St. Rank hold INDP as of Q3 2021.

AdvisorShares Investments reported no remaining Indaptus Therapeutics position as of Q3 2021 after selling out during the quarter.
AdvisorShares Investments sold 3,955 Indaptus Therapeutics shares in Q3 2021, an estimated $1.54M.
AdvisorShares Investments first reported a position in Indaptus Therapeutics in Q4 2019 and held it in 7 quarters.
AdvisorShares Investments's Indaptus Therapeutics position peaked at $1.94M in Q1 2021.
14 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2021.

Based on AdvisorShares Investments's 13F filing for Q3 2021, filed 4 Nov 2021.